Pepti-drift: Scalable Safe-Active Peptide Generation Without Inference-Time Guidance
Therapeutic peptides are a promising drug modality, but their generation must satisfy multiple therapeutic constraints. We introduce BindSafe-PepBench, a fixed-budget benchmark that jointly evaluates target binding and four major safety metrics on the same generated candidates. We reveal that peptide length is a major confounder of joint binding-safety evaluation: longer peptides tend toward stronger predicted binding but less favorable predicted safety. This creates an apparent trade-off and can bias comparisons among models with different output-length distributions. We report absolute Safe-Active yield and exact-length-matched gains to distinguish generative improvements from output-length effects. High Safe-Active yield remains challenging, while the strongest multi-property methods rely on costly inference-time guidance. We therefore introduce Pepti-drift, a one-step generation framework that incorporates attraction toward target-specific binders and repulsion from liability-associated regions, requiring a single latent refinement followed by parallel decoding without inference-time guidance. Across 88 held-out targets, Pepti-drift achieves an 18.37% predicted Safe-Active yield while retaining positive exact-length-matched gains. The resulting gains are competitive with multi-property-guided baselines while requiring 468 times lower generation cost, enabling scalable and fair high-throughput peptide design.